PTSM: Pharmaceutical Technology Sourcing and Management, Dec 7, 2011 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
PTSM: Pharmaceutical Technology Sourcing and Management, Dec 7, 2011
Global Feature
Patent Reform and the Pharmaceutical Industry: From First-To-File To Post-Grant Review And Beyond
By Courtenay C. Brinckerhoff
The author discusses the major changes in US patent laws as a result of the recently signed patent-reform law and the implications for pharmaceutical companies.
APIs
Technical Perspective: Antibody Drug Conjugates
By Patricia Van Arnum
A podcast moderated by Patricia Van Arnum, executive editor of Pharmaceutical Technology.
Outsourcing
Biosimilars' Technology Needs
By Eric Langer
Biosimilar manufacturers need better expression systems and analytical tools to compete.
CSR and Sustainability Forum
Pharmaceutical Companies Target Green Manufacturing
A roundup of pharmaceutical companies' sustainability objectives and key projects.
World Health Organization Issues Progress Report on Combating HIV/AIDS
By Patricia Van Arnum
International efforts, including improving access to medicines, have contributed to stemming the rise of HIV/AIDS in the developing world.
CSR and Sustainability in the News
By Patricia Van Arnum
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other private and public organizations.

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here